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Abstract
In this work, we studied the effect of intracellular 3¢,5¢-cyclic
adenosine monophosphate (cAMP) on Li+ transport in SH-
SY5Y cells. The cells were stimulated with forskolin, an
adenylate cyclase activator, or with the cAMP analogue, dibu-
tyryl-cAMP. It was observed that under forskolin stimulation
both the Li+ influx rate constant and the Li+ accumulation in
these cells were increased. Dibutyryl-cAMP also increased Li+
uptake and identical results were obtained with cortical and
hippocampal neurons. The inhibitor of the Na+/Ca2+ exchan-
ger, KB-R7943, reduced the influx of Li+ under resting condi-
tions, and completely inhibited the effect of forskolin on the
accumulation of the cation. Intracellular Ca2+ chelation, or inhi-
bition of N-type voltage-sensitive Ca2+ channels, or inhibition
of cAMP-dependent protein kinase (PKA) also abolished the
effect of forskolin on Li+ uptake. The involvement of Ca2+ on
forskolin-induced Li+ uptake was confirmed by intracellular free
Ca2+ measurements using fluorescence spectroscopy. Expo-
sure of SH-SY5Y cells to 1 mM Li+ for 24 h increased basal
cAMP levels, but preincubation with Li+, at the same concen-
tration, decreased cAMP production in response to forskolin.
To summarize, these results demonstrate that intracellular
cAMP levels regulate the uptake of Li+ in a Ca2+-dependent
manner, and indicate that Li+ plays an important role in the
homeostasis of this second messenger in neuronal cells.
Keywords: calcium, cAMP, forskolin, lithium, Na+/Ca2+
exchanger.
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Lithium salts have been used clinically for more than
50 years as mood-stabilizing agents in the treatment of
bipolar disorder, a severe, chronic and often life-threatening
disease that affects 1% of the world population (Goodwin
and Jamison 1990). Plasma Li+ concentrations in the range of
0.5–1.2 mM are correlated with the clinical efficacy in most
patients, but toxic effects are often encountered when the
plasma concentration exceeds 2 mM. Despite the well-
documented therapeutic effectiveness of Li+, the biochemical
basis of this Li+ action is not completely understood (Manji
et al. 1995; Jope 1999a).
It has been reported that Li+ inhibits several cellular
enzymes, most of them involved in signal transduction
pathways, such as glycogen synthase kinase-3b (Williams
and Harwood 2000; Ryves and Harwood 2001; Jope 2003),
inositol monophosphatase (Allison and Stewart 1971; Hall-
cher and Sherman 1980) and adenylate cyclase (AC)
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(Newman and Belmaker 1987; Mørk and Geisler 1989a).
This inhibitory in vitro effect of Li+ has been attributed to a
competition between Li+ and Mg2+ for Mg2+ binding sites in
several biomolecules due to their similar physicochemical
properties (Mørk and Geisler 1987a; Ramasamy and Mota de
Freitas 1989; Mota de Freitas et al. 1994; Amari et al. 1999;
Layden et al. 2000; Ryves and Harwood 2001). Several
studies have demonstrated that Li+ affects 3¢,5¢-cyclic
adenosine monophosphate (cAMP) levels (Dousa and Hech-
ter 1970; Mørk and Geisler 1987a,b; Newman and Belmaker
1987). The molecular mechanisms involved are still unclear,
although the Li+–Mg2+ competition seems to participate in
the inhibitory in vitro effect of Li+ on AC activity (Newman
and Belmaker 1987; Mørk and Geisler 1989a,b). Li+ reduces
cAMP production stimulated by agents operating down-
stream of the receptor [e.g. forskolin (Newman and Belmaker
1987; Andersen and Geisler 1984; Mørk and Geisler 1989a)
and calcium-calmodulin (Mørk and Geisler 1987a,b; 1989c)]
and decreases both receptor-mediated stimulation (Ebstein
et al. 1980; Newman and Belmaker 1987; Mørk and Geisler
1989b; Carli et al. 1994) or receptor inhibition of AC activity
in the rat brain (Ebstein et al. 1980; Newman et al. 1990).
Moreover, Li+ alters the activity of guanine-nucleotide
binding proteins (G-proteins) regulating the activity of AC
(Avissar et al. 1988; Masana et al. 1992). Two main types of
G-proteins, Gs and Gi, mediating stimulatory and inhibitory
signaling, respectively, may account for both the antimanic
and antidepressant therapeutic effects of Li+ (Avissar et al.
1988; Manji 1992; Jope 1999b). Findings of high Gas levels
(Young et al. 1993; Friedman and Wang 1996) and increased
forskolin-stimulated cAMP formation (Young et al. 1993) in
cerebral cortical regions of post mortem brains from bipolar
untreated patients support the hypothesis that a hyperactive G
protein-coupled cAMP signaling system may be involved in
the pathophysiology of this disease (Chang et al. 2003).
In human erythrocytes and in other cellular models Li+ can
partially replace Na+ in a number of ion transport systems.
These include the voltage-sensitive Na+ channels (VSSC)
(Ehrlich and Diamond 1980; Nikolakopoulos et al. 1998),
the coupled active transport of Na+ and K+ (Beauge´ 1978;
Layden et al. 2003), the cotransport of Na+/K+/Cl– (Pandey
et al. 1978), and the Na+/Ca2+ (Abajo et al. 1987; De la
Fuente et al. 1996; Deval et al. 2002; Fonseca et al. 2004),
the Na+/H+ (Busch et al. 1995) and the Na+/Li+ (Sarkadi
et al. 1978) exchangers.
As cAMP levels have been suggested to be abnormal in
bipolar patients, it is of interest to know whether this second
messenger regulates Li+ transport into neurons. Moreover, it is
important to determine the effect of Li+ on the homeostasis of
intracellular cAMP levels. In this work we investigated the
effect of intracellular cAMP on Li+ uptake, at therapeutic
plasma concentrations, in undifferentiated SH-SY5Y human
neuroblastoma cells and in primary cultures of rat cortical and
hippocampal neurons. This was assessed by using forskolin
which is a diterpene derivative that activates AC, raising
cAMP levels in the cells (Seamon et al. 1981), and the cell
membrane penetrating cAMPanalogue, dibutyryl-cyclic AMP
(db-cAMP). The pathways involved in Li+ uptake, under
resting or forskolin conditions, and the effect of Li+ on the
cAMP production in SH-SY5Y cells were also studied.
Materials and methods
Materials
The human neuroblastoma SH-SY5Y cell line was provided by Dr E.
Stubbs Jr (Department of Neurology, Loyola University Medical
Center, Chicago, IL, USA). Neurobasal medium, B27 supplement,
gentamicin and trypsin (USP grade) were purchased from Gibco
Invitrogen Corporation (Paisley, Scotland, UK). Fura-2/AM and
Pluronic F-127 were supplied by Molecular Probes (Leiden, the
Netherlands) and RO-201724 and KT-5720 by Biomol (Plymouth
Meeting, PA, USA). The [8-3H] cAMP assay kit (TRK 432), BCA
reagent and fetal calf serum (FCS) were obtained from Amersham
Biosciences (Buckinghamshire, UK), Pierce (Rockford, IL, USA) and
BioWhittaker Europe (Verviers, Belgium), respectively. Tetrodotoxin
(TTX) and KB-R7943 were purchased from Tocris Cookson
(Avonmouth, UK). All other reagents were from Sigma Chemical
Company (Madrid, Spain) or from Merck (Darmstadt, Germany).
Culture of the human neuroblastoma SH-SY5Y cells
SH-SY5Y cells were grown in 75 cm2 polystyrene culture flasks, at
37C, in a humidified atmosphere of 5% CO2/95% air. Cells were
grown in Dulbecco’s modified Eagle’s medium (DMEM) buffered
with 18 mM NaHCO3 (pH 7.35), and supplemented with 10% (v/v)
FCS, penicillin (100 U/mL) and streptomycin (100 lg/mL), and
harvested by using a phosphate-buffer dissociation solution (in mM:
5.6 glucose, 58.4 sucrose, 137 NaCl, 0.2 NaH2PO4, 0.2 KHPO4 and
5.4 KCl, pH 7.4) (Stubbs and Agranoff 1993).
To determine intracellular Li+ and cAMP levels, SH-SY5Y cells
were seeded on six-well plates, at a density of 1.5 · 105 cells/cm2, and
the experiments were carried out 3 days after the subculture. The
intracellular free calcium concentration ([Ca2+]i) was measured using
SH-SY5Ycells cultured on 1 cm2 glass coverslips, at an initial density
of 1 · 104 cells/cm2, and the cells were used 2 days after the
subculture. To test cell viability during incubation of Li+, the cells
were seeded in 24-well plates, at a density of 1.5 · 105 cells/cm2, and
were incubated with LiCl for 48 h, after the subculture.
Preparation of rat cortical neurons
Primary cultures of cortical neurons were prepared from 15 to
16 days old Wistar rat embryos according to the method previously
described (Hertz et al. 1989), with some modifications. Briefly, the
neocortices were dissected and placed in Ca2+- and Mg2+-free Krebs
buffer (in mM: 120 NaCl, 4.8 KCl, 1.2 KH2PO4, 13 glucose, 10
HEPES, pH 7.4) supplemented with 0.3% bovine serum albumin
(BSA). After removing the meninges the neocortices were washed
and incubated in Ca2+- and Mg2+-free Krebs buffer containing
0.02% trypsin and 0.04% DNase I, for 10 min, at 37C. The
digestion was stopped with Ca2+- and Mg2+-free Krebs buffer
containing 0.05% trypsin inhibitor (type II-S) and 0.004% DNase I,
and the tissue was centrifuged at 140 · g for 5 min. After washing
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the pellet once more with Ca2+- and Mg2+-free Krebs buffer the cells
were dissociated mechanically. Cortical cells were cultured in
Neurobasal medium supplemented with 2 mM L-glutamine, 2% B27
supplement, penicillin (100 U/mL), and streptomycin (100 lg/mL).
The cells were plated on poly D-lysine (0.1 mg/mL)-coated
multiwell plates, at a density of 0.15 · 106 cells/cm2, and the
cultures were maintained for 7 days, at 37C, in a humidified
atmosphere of 5% CO2/95% air.
Preparation of rat hippocampal neurons
The cells were dissociated from the hippocampi of 18–19 days old
Wistar rat embryos, after treatment with trypsin (2.0 mg/mL,
15 min, 37C) and DNase I (0.15 mg/mL) in Ca2+- and Mg2+-free
Hank’s balanced salt solution (in mM: 137 NaCl, 5.36 KCl, 0.44
KH2PO4, 0.34 Na2HPO4.2H2O, 4.16 NaHCO3, 5 glucose, 1 sodium
pyruvate, 10 HEPES, pH 7.4). The cells were cultured in serum-free
Neurobasal medium, supplemented with B27 supplement, glutamate
(25 lM), glutamine (0.5 mM) and gentamicin (0.12 mg/mL), as
described previously (Brewer et al. 1993). The cells were plated on
poly-D-lysine (0.1 mg/mL)-coated multiwell plates at a density of
0.1 · 106 cells/cm2. Cultures were kept for 7 days, at 37C, in a
humidifed atmosphere containing 5% CO2/95% air.
Intracellular Li+ measurements
Before the experiments, the culture medium of SH-SY5Y cells was
replaced by DMEM without FCS. When cortical and hippocampal
neurons were used, the culture medium was not changed because it
was free of FCS. Cells were preincubated for 15 min with the cAMP
phosphodiesterase 4 selective inhibitor, RO-201724 (25 lM) (Reeves
et al. 1987). Then cells were incubated with forskolin (10 lM;
preincubation during 15 min) or db-cAMP (500 lM; preincubation
during 30 min). LiCl at 1 mM concentration was then added to the
medium and, at the indicated time points (5, 15, 30, 45, 60 or
120 min), the cells were washed with an ice-cold choline phosphate
buffered solution (PBS) (in mM: 137 choline-Cl, 2.7 KCl, 1.4
K2HPO4 and 4.3Na2HPO4, pH 7.35) to remove extracellular Li
+. The
use of a Na+-free choline-Cl medium prevents Li+ efflux (Nikolak-
opoulos et al. 1998). The cells were lysed with 0.15 M perchloric acid
and the lysate was centrifuged at 15 800 · g (Eppendorf, 5417R),
during 5 min, at 4C. The supernatants were analyzed by atomic
absorption (AA) spectrophotometry using a Perkin ElmerAnalyst 100
spectrometer equipped with a flame source. The total intracellular Li+
concentrations, [Li+]iT, were calculated from the AA measurements
using a calibration curve (Li absorption versus Li+ concentration).
This calibration curve was obtained bymeasuring the Li absorption of
three standard solutions, with three different LiCl concentrations:
0.1 mM, 0.2 mM and 0.4 mM LiCl. The kinetics of Li+ influx in these
cells was calculated using the equation:
½LiþiT ¼ ½Liþi1½1 expðkiÞðtÞ ð1Þ
where ki is the Li
+ influx rate constant, [Li+]iT and [Li
+]i¥ are the
total intracellular Li+ concentrations at the different time points (t)
and when Li+ concentration has reached a steady state, respectively.
Measurements of [Ca2+]i in SH-SY5Y cells
The SH-SY5Y cells were preincubated or not with the tested
drugs, for the indicated periods of time. The cells were then
loaded with 5 lM fura-2/AM and 0.2% pluronic F-27 in Krebs
buffer (in mM: 132 NaCl, 4 KCl, 1.4 MgCl2, 1 CaCl2, 6 glucose,
10 HEPES, pH 7.35) supplemented with 0.1% fatty acid-free
BSA, for 40 min, at 37C. A further incubation for 10 min in the
same medium, without fura-2/AM and pluronic F-27, was made to
obtain a complete hydrolysis of the probe. Coverslips were rinsed
with Krebs buffer and mounted, with a special holder (Perkin-
Elmer L2250008), in a temperature-controlled cuvette chamber.
The fluorescence of fura-2-loaded cells was monitored using a
computer-assisted Spex Fluoromax spectrofluorimeter, at 510 nm
emission and double excitation at 340 nm and 380 nm, using
5 nm slits. The calibration was made in the presence of 6 lM
ionomycin (1 mM CaCl2; Rmax), at 800 s, and 8 mM EGTA (Rmin),
at 1000 s. The fluorescence intensities were converted into [Ca2+]i
values using the calibration equation for double excitation
wavelength measurements and the value of 224 nM was used for
the dissociation constant (Kd) of the fura-2/Ca
2+ complex
(Grynkiewicz et al. 1985):
½Ca2þi ¼ Kd  ðR RminÞ=ðRmax  RÞ  Sf380=Sb380 ð2Þ
where R is the ratio of the fluorescence intensity of the probe at
340 nm, F340, and at 380 nm, F380; Sf380 and Sb380 are the
fluorescence intensities at 380 nm for the free and Ca2+-saturated
dye, respectively.
[3H]cAMP determination in SH-SY5Y cells
The cAMP levels were measured in control and forskolin-stimulated
cells, in the presence or absence of 1 mM LiCl (preincubation times:
1, 24 and 48 h). The cells were preincubated in the presence of
RO-201724 (25 lM) for 15 min, and then further treated with
forskolin (10 lM), for 15 min. The medium was then removed and
the cells were scraped in 1 mL of 50 mM Tris/4 mM EDTA buffer,
pH 7.35, after washing with an ice-cold PBS solution. The extracts
were boiled at 90C, for 4 min, and centrifuged at 14 000 · g
(Eppendorf, 5417R), for 5 min, at 4C. Supernatants were used to
quantify cAMP levels. Protein content in the pellets was determined
by the bicinchoninic acid assay. Levels of cAMP in SH-SHSY cells
were measured with an [8-3H]cAMP assay kit (Amersham, TRK
432). Binding protein and [8-3H]cAMP tracer were added to
duplicated samples, which were kept cold (2–8C) for 2 h. A
charcoal suspension (100 lL) was then added to the samples before
centrifugation at 14 000 · g for 5 min. A 200 lL supernatant
fraction of each sample was removed for scintillation counting. The
cAMP levels were estimated by comparing the radioactivity of each
sample with that of known standards.
Assessment of cell viability
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay was used to test cell viability after treatment of SH-
SY5Y cells with different concentrations of LiCl (0.5, 1, 5 and
15 mM) during 48 h. MTT, when taken up by living cells, is
converted from yellow to a water insoluble blue-colored precipitate
by cellular dehydrogenases (Mosmann 1983). Cell cultures were
incubated for 1 h, at 37C, with a Krebs buffer containing MTT
(0.5 mg/mL). The precipitated dye was dissolved by addition of
0.04 M HCl in isopropanol and the optical density was colori-
metrically measured at 570 nm, using an ELISA plate reader.
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Data analysis
Data are expressed as means ± SEM and p < 0.05 was considered
significant. Statistical significance was determined by using analysis
of variance (ANOVA), followed by Bonferroni’s post hoc test, except
in the kinetic studies where the Student’s t-test was used.
Results
Effect of intracellular cAMP on Li+ uptake by neuronal
cells
To determine the effect of intracellular cAMP on Li+ uptake
by neuronal cells, forskolin was used as an activator of AC
activity (Seamon et al. 1981), and the amount of Li+ inside
the cells was measured by AA spectrophotometry. The
kinetics of Li+ influx into SH-SY5Y cells was studied in the
absence or presence of forskolin, under exposure to 1 mM Li+.
This concentration is in the range of therapeutic concentra-
tions used in the treatment of bipolar disease. Figure 1(a)
shows that the Li+ influx rate constant (ki) value was higher in
cells stimulated with forskolin than in the control situation
(ki ¼ 0.041 ± 0.005 per min versus the control value ki ¼
0.028 ± 0.005 per min; p < 0.05). The total amount of Li+
accumulated by the cells was higher when the intracellular
cAMP content was raised, particularly for 30 min incubation
with Li+ (27.6 ± 1.8 nmol/mL versus the control value
17.9 ± 1.7 nmol/mL; p < 0.01). In order to confirm that
these effects were due to an increase in intracellular cAMP
and not to a non-specific effect of forskolin, experiments with
db-cAMP were performed. Figure 1(b) compares the effect of
forskolin and db-cAMP on the uptake of Li+ by the SH-SY5Y
cells exposed to the cation (1 mM) for 30 min. Li+ uptake by
cells incubated with forskolin and db-cAMP was not signi-
ficantly different, but it was significantly higher than the
control [126.9 ± 11.6% for forskolin (p < 0.01) and
142.6 ± 13.9% for db-cAMP (p < 0.001)].
Similar results were obtained with rat cortical
[133.5 ± 5.9% for forskolin (p < 0.01) and 154.0 ± 9.3%
for db-cAMP (p < 0.001)] and hippocampal neurons
[133.3 ± 11.9% for forskolin (p < 0.05) and 141.4 ± 6.9%
for db-cAMP (p < 0.05)] (Fig. 2a,b).
Li+ influx pathways in SH-SY5Y cells
In order to investigate the transport pathways responsible for
Li+ uptake by SH-SY5Y cells, inhibitors or blockers of the
main transport systems present in the plasma membrane of
these cells were used, in control (Fig. 3) and forskolin-
stimulated cells (Fig. 4a,b). The amount of Li+ taken up by
the cells was determined by AA spectrophotometry after 30-
min exposure to 1 mM Li+. The contribution of VSSC,
N-type voltage-sensitive Ca2+ channel (VSCC), Na+/Ca2+
exchanger and L-type voltage-sensitive Ca2+ channels
(L-type VSCC) for Li+ uptake was tested using tetrodotoxin
(TTX), x-CgTx GVIA, KB-R7943 and nifendipine, respect-
ively. The effect of protein kinase A (PKA) and of the
intracellular free Ca2+ concentration ([Ca2+]i) was also tested,
using KT-5720 (PKA inhibitor) and BAPTA (Ca2+ chelator),
respectively. The concentrations used of x-CgTx GVIA
and nifendipine were according to published data with
Fig. 1 Kinetics of Li+ influx in SH-SY5Y cells, in the absence (s) (ctrl)
and in the presence (d) of forskolin (fsk) (a). The cells were prein-
cubated with RO-201724 (25 lM), for 15 min, and then with fsk
(10 lM), for 15 min. LiCl at 1 mM concentration was then added to the
medium and at 5, 15, 30, 45, 60 or 120 min the amount of Li+ taken up
by cells was measured by AA spectrophotometry. The rate constants
obtained for Li+ influx were 0.028 ± 0.005 per min (ctrl) and
0.041 ± 0.005 per min (fsk) (p < 0.05). Values are means ± SEM of
4–20 independent experiments. (b) Li+ uptake by SH-SY5Y cells
pretreated or not (ctrl) with fsk (10 lM; 15 min) or db-cAMP (500 lM;
30 min), in the presence of RO-201724 and before incubation with Li+,
for 30 min. The total intracellular Li+ was measured by AA spectro-
photometry, as described in the methods section. Data are presented
as a percentage of intracellular Li+ content relative to the control.
Values are means ± SEM for the indicated number of independent
experiments. **p < 0.01; ***p < 0.001, significantly different from
control; ns, not significant.
Fig. 2 Effect of fsk on Li+ uptake by cortical (a) or hippocampal neu-
rons (b). After preincubating the cells with RO-201724 (25 lM), for
15 min, they were pretreated or not (ctrl) with 10 lM fsk (15 min) or
500 lM db-cAMP (30 min) and later incubated with 1 mM LiCl for
30 min. The total amount of intracellular Li+ was measured by AA
spectrophotometry. Data are presented as a percentage of total
intracellular Li+ content relative to the control. Values are means ±
SEM, for the indicated number of independent experiments. *p < 0.05;
**p < 0.01; ***p < 0.001, significantly different from control; ns, not
significant.
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undifferentiated SH-SY5Y cells (Reeve et al. 1994; Hirota
and Lambert 1997). The other drugs were used at a
concentration that produces a maximal effect under our
experimental conditions (data not shown).
Figure 3 shows that under resting conditions the Na+/Ca2+
exchanger is the main transport pathway responsible for Li+
influx, as there was a significant decrease in Li+ uptake in the
presence of KB-R7943 relative to the control (56.4 ± 8.6%;
p < 0.001). None of the other inhibitors tested affected Li+
uptake by SH-SY5Y cells under resting conditions.
Similar experiments were performed using cells preincu-
bated with forskolin in order to determine the identity of the
transport pathway(s) responsible for the increase in Li+
uptake induced by intracellular accumulation of cAMP
(Fig. 4a,b). The increase of Li+ uptake observed under
forskolin stimulation (126.9 ± 11.6%) was most significantly
reduced by inhibition of the Na+/Ca2+ exchanger
(50.4 ± 7.3%; p < 0.001), as shown in Fig. 4(b), indicating
that this transport system plays the most relevant role in Li+
uptake. Under the same conditions, it was observed that the
increase in Li+ uptake was also significantly reduced in the
presence of KT-5720 (97.5 ± 11.2%; p < 0.01), x-CgTx
GVIA (88.1 ± 9.2%; p < 0.001) and BAPTA (86.3 ± 4.6%;
p < 0.001), whereas nifendipine (107.4 ± 6.9%; p > 0.05)
and TTX (118.1 ± 2.0%; p > 0.05) did not affect significantly
the accumulation of Li+ (Fig. 4a,b). Under both resting and
stimulating conditions, the uptake of Li+ by cells incubated
simultaneously with KB-R7943 and nifendipine (61.9 ±
13.0% under basal conditions and 56.3 ± 4.1% after forsk-
olin stimulation) was not significantly different from that
observed in the presence of KB-R7943 alone (56.4 ± 8.6%
for basal conditions and 50.4 ± 7.3% for forskolin) (Figs 3
and 4b).
Determination of [Ca2+]i
As interference with the Ca2+ homeostasis mechanism
affected Li+ uptake, [Ca2+]i was measured under the
experimental conditions used in the Li+ studies, using the
Ca2+ sensitive fluorescence probe fura-2 (Grynkiewicz et al.
1985). The experiments were carried out under resting
conditions (Fig. 5a) and upon forskolin stimulation (Fig. 5b),
using the same inhibitors and blockers employed in the study
of Li+ influx pathways.
The results in Fig. 5(a) show that the inhibitors used did
not affect the resting [Ca2+]i (78.0 ± 5.5 nM), except KB-
R7943, which increased significantly [Ca2+]i (106.9 ±
3.8 nM; p < 0.01). The [Ca2+] increase after forskolin
Fig. 3 Pharmacological characterization of Li+ uptake by SH-SY5Y
cells under resting conditions. The cells were pretreated with RO-
201724 (25 lM), for 15 min, and then with the following drugs, at dif-
ferent concentrations and preincubation times: TTX (1 lM; 5 min),
x-CgTx GVIA (0.5 lM; 30 min), KT-5720 (10 lM; 10 min), BAPTA-AM
(10 lM; 30 min), KB-R7943 (20 lM; 5 min) and nifendipine (Nif, 1 lM;
5 min), to study the contribution of VSSC, N-type VSCC, PKA, [Ca2+]i,
Na+/Ca2+ exchanger and L-type VSCC, respectively. LiCl at 1 mM
concentration was added to the medium and at 30 min the amount of
Li+ taken up by cells was measured by AA spectrophotometry. Total
intracellular Li+ content is presented as a percentage relative to the
control. Values are means ± SEM, for the indicated number of inde-
pendent experiments. ***p < 0.01, significantly different from control.
Fig. 4 Pharmacological characterization of Li+ uptake by SH-SY5Y
cells incubated with fsk. The cells were pretreated with RO-201724
(25 lM), for 15 min, and the contribution of VSSC, PKA and [Ca2+]i to
the fsk-induced Li+ uptake was studied by using TTX (1 lM; preincu-
bation during 5 min), KT-5720 (10 lM; preincubation during 10 min)
and BAPTA-AM (10 lM; preincubation during 30 min), respectively (a).
The contribution of the N- and L-type VSCC, and of the Na+/Ca2+
exchanger, to the fsk-induced increase in Li+ uptake was investigated
using x-CgTx GVIA (0.5 lM; preincubation during 30 min), Nif (1 lM;
preincubation during 5 min) and KB-R7943 (20 lM; preincubation
during 5 min), respectively (b). After exposure to the drugs, the cells
were incubated with fsk (10 lM), for 15 min, and then 1 mM LiCl was
added to the medium. At 30 min the amount of Li+ taken up by the
cells was measured by AA spectrophotometry. Total intracellular Li+
content is presented as a percentage relative to the control. Values
are means ± SEM, for the indicated number of independent experi-
ments. **p < 0.01, significantly different from control; ++p < 0.01;
+++p < 0.001, significantly different from fsk stimulation in the absence
of any of these drugs.
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stimulation was inhibited in the presence of KT-5720
(74.9 ± 5.3 nM; p < 0.01), x-CgTx GVIA (65.8 ± 2.6 nM;
p < 0.01) or BAPTA (63.2 ± 10.6 nM; p < 0.01) (Fig. 5b).
In contrast, inhibition of the Na+/Ca2+ exchanger with
KB-R7943 further increased the [Ca2+]i in cells stimulated
with forskolin (138.6 ± 7.4 nM; p < 0.05), whereas nifendi-
pine and TTX were without effect.
Determination of intracellular cAMP levels
The results of Figs 1, 2 and 4 show that cAMP levels affect
Li+ uptake. We then investigated whether Li+ taken up by
SH-SY5Y cells modulates cAMP production, using a
radioactive biochemical assay. Figure 6 shows the intracel-
lular cAMP content under control conditions and the effect of
exposure to 1 mM of Li+ during 1, 24 and 48 h, under basal
conditions (Fig. 6a) and after forskolin stimulation (Fig. 6b).
Exposure of the cells to Li+, for 1 h, did not affect cAMP
levels when compared to the control (84.7 ± 27.0%;
p > 0.05), but longer incubations with Li+ increased the
cAMP content in a time-dependent manner (4 h,
152.2 ± 38.4%; 6 h, 198.9 ± 8.3%; 10 h, 279.2 ± 8.3%)
(data not shown) and a maximal effect was obtained after
24 h incubation with Li+ (358.2 ± 6.9%; p < 0.001). This
enhancement was maintained after 48 h of Li+ exposure
(374.5 ± 4.6%, p < 0.001) (Fig. 6a). As expected, forskolin
stimulation significantly increased intracellular cAMP levels
relative to the control (509.2 ± 40.9%; p < 0.001), and this
effect was partially inhibited in cells pre-exposed to Li+ for
1 h (246.1 ± 40.4%; p < 0.01). Similar results were obtained
in cells incubated with Li+ for 24 h (250.0 ± 22.9%;
p < 0.01) or 48 h (261.0 ± 40.3%; p < 0.01) (Fig. 6b).
In order to check the metabolic and physiological
conditions of SH-SY5Y cells in these experiments, cell
viability was monitored after exposure to 1 mM of Li+ for
48 h. Figure 6(c) shows that no significant changes in
viability relative to the control were observed when the cells
were treated during 48 h with Li+ concentrations up to 5 mM.
Discussion
The present study demonstrates that activation of AC with
forskolin increases Li+ uptake by SH-SY5Y cells and by
Fig. 5 Pharmacological characterization of the pathways for [Ca2+]i
homeostasis in SH-SY5Y cells under resting conditions (a) and after
stimulation with fsk (b). Cells were pretreated with RO-201724
(25 lM), for 15 min, and then with x-CgTx GVIA (0.5 lM; preincuba-
tion during 30 min), Nif (1 lM; preincubation during 5 min), KB-R7943
(20 lM; preincubation during 5 min), KT-5720 (10 lM; preincubation
during 10 min) or TTX (1 lM; preincubation during 5 min), to test the
contribution of N- and L-type VSCC, Na+/Ca2+ exchanger, PKA and
VSSC, respectively, to the maintenance of the [Ca2+]i. The effect of the
Ca2+ chelator, BAPTA, was also determined by preincubating the cells
with 10 lM BAPTA-AM, for 30 min. The cells were stimulated or not
with 10 lM fsk, for 15 min, and the [Ca2+]i was measured by fluores-
cence spectroscopy using fura-2. Values are means ± SEM, for the
indicated number of independent experiments. **p < 0.01; significantly
different from control; +p < 0.05; ++p < 0.01, significantly different from
fsk stimulation in the absence of any drug.
Fig. 6 Effects of Li+ on cAMP production by SH-SY5Y cells. (a) Cells
were pretreated with RO-201724 (25 lM), for 15 min, and then incu-
bated or not (ctrl) with 1 mM Li+, for the indicated periods of time. (b)
Where indicated, the cells were stimulated with 10 lM fsk, for 15 min,
after treatment with Li+. The cAMP levels were measured as described
in the methods section. (c) MTT biochemical assay with SH-SY5Y
cells treated with LiCl (0, 0.5, 1, 5 and 15 mM), during a period of 48 h.
Data are presented as a percentage relative to the control. Values are
means ± SEM, for the indicated number of independent experiments.
*p < 0.05; ***p < 0.001, significantly different from the control.
++p < 0.01, significantly different from fsk stimulation in the absence of
Li+.
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cultured hippocampal and cortical neurons, at therapeutic
concentrations of the cation. The effect of cAMP in SH-
SY5Y cells was mediated by PKA and occurred via changes
in the [Ca2+]i. Accordingly, intracellular accumulation of
cAMP increased the [Ca2+]i due to Ca
2+ entry through
N-type VSCC, and inhibition of these channels with x-CgTx
GVIA also inhibited the effect of cAMP on Li+ uptake. SH-
SY5Y cells used in the present work as a neuronal model are
electrically excitable and express VSSC (Forsythe et al.
1992), L- and N-type VSCC (Lambert et al. 1990; Reeve
et al. 1994; Hirota and Lambert 1997), and the Na+/Ca2+
exchanger (Nakamura et al. 2000).
Under resting conditions the uptake of Li+ by SH-SY5Y
cells was partially inhibited (about 40%) by the Na+/Ca2+
exchanger inhibitor KB-R7943, indicating that in non-
stimulated cells, Li+ influx is accompanied by the efflux of
Ca2+. This role of the Na+/Ca2+ exchanger in the mainten-
ance of the [Ca2+]i in control cells is supported by the results
showing an increase of the [Ca2+]i in the presence of the
inhibitor of the antiporter. A similar effect of KB-R7943 on
the [Ca2+]i under resting conditions was previously reported
in cardiomyocytes (Iwamoto et al. 1996). In agreement with
the present findings, Li+ has been shown to replace Na+ in
many exchange pathways (Beauge´ 1978; Pandey et al. 1978;
Sarkadi et al. 1978; Ehrlich and Diamond 1980; Busch et al.
1995; Layden et al. 2003), including the Na+/Ca2+ antiporter
(Abajo et al. 1987; De la Fuente et al. 1996; Deval and
Cognard 2002; Fonseca et al. 2004). A fraction of Li+ uptake
by SH-SY5Y cells, under resting conditions and after
forskolin stimulation, was insensitive to the Na+/Ca2+
exchanger inhibitor. The remaining contribution probably
arises from a leak, which represents passive permeation
through pores in the membrane (Ehrlich and Diamond 1980).
As expected, inhibition of N- and L-type VSCC and of
VSSC was without effect on Li+ uptake under resting
conditions, indicating that these pathways do not contribute
to the influx of the cation in non-stimulated conditions.
Forskolin stimulation increased the Li+ influx rate con-
stant, ki, in SH-SY5Y cells, indicating that cAMP activates
Li+ transport pathways that are not involved in the transport
of the cation under resting conditions. The Ca2+ chelator
BAPTA inhibited forskolin-induced Li+ uptake, and was
without effect on the accumulation of Li+ under resting
conditions, indicating that the transport pathway activated by
cAMP is dependent on a rise in the [Ca2+]i. Because x-CgTx
GVIA, a N-type VSCC blocker, inhibited the accumulation
of Li+ induced by forskolin, Ca2+ influx through these
channels is likely to be involved in the activation of the Li+
uptake pathway. VSCC are not permeable to Li+ (Corry et al.
2001) and therefore the forskolin-induced Li+ uptake must be
secondary to the [Ca2+]i rise due to activation of N-type
VSCC. In contrast to the role of N-type VSCC in the uptake
of Li+ induced by cAMP, inhibition of L-type VSCC did not
affect Li+ uptake by SH-SY5Y cells after stimulation with
forskolin. Although undifferentiated SH-SY5Y cells express
both L- and N-type VSCC (Lambert et al. 1990; Reeve et al.
1994; Hirota and Lambert 1997) the latter are predominantly
expressed and play a major role in Ca2+ entry (Seward and
Henderson 1990; Forsythe et al. 1992; Reuveny and
Narahashi 1993). This may explain the differences observed
in their relative role in Li+ uptake under our experimental
conditions.
As previously stated, the effect of forskolin on the uptake of
Li+ and on the [Ca2+]i was inhibited by the PKA inhibitor, KT-
5720, which is in agreement with evidences indicating that
PKA is the most important target of cAMP (Skalhegg and
Tasken 2000). PKA is known to phosphorylate several
neuronal proteins, including ion channels (Scott 1991; Walaas
and Greengard 1991; Spaulding 1993). Accordingly, cAMP
increasing agents have been shown to activate Na+ influx
currents through non-selective cation channels, insensitive to
TTX, thereby depolarizing the cells and leading to the
activation of N- and L-type VSCC (Holz et al. 1995; Kato
et al. 1996; Takano et al. 1996; Leech and Habener 1998;
Miura and Matsui 2003). Although PKA may regulate the
activity of VSCC by phosphorylation (Gross et al. 1990;
Ahlijanian et al. 1991; Meuth et al. 2002), this effect requires
membrane depolarization to activate the channels. Therefore,
phosphorylation of VSCC by PKA cannot account directly for
the increased Ca2+ influx observed in forskolin stimulated
cells, which causes a rise of intracellular Li+ transport.
Low concentrations of KB-R7943 (0.3–10 lM) inhibit
preferentially the reverse mode of the Na+/Ca2+ transporter,
and higher concentrations (30 lM) are required to reduce the
forward mode of the exchanger (Iwamoto et al. 1996). At the
concentration used in the present study (20 lM) KB-R7943
decreased Li+ uptake by SH-SY5Y cells, under resting
conditions and following stimulation of AC, to about the
same levels. These results indicate that Li+ is taken up by the
Na+/Ca2+ antiporter, most likely in exchange with intracel-
lular Ca2+. Furthermore, the results show that activation of
the Na+/Ca2+ exchanger fully accounts for the up-regulation
of Li+ uptake in cells exposed to forskolin. This is probably
due to the [Ca2+]i rise induced by cAMP, which is likely to
activate the Na+/Ca2+ (Li+/Ca2+) exchanger in order to
extrude the Ca2+ taken up by the cells. Although the Na+/
Ca2+ exchanger has a low-affinity for Ca2+ it has a high
capacity of transport, thereby contributing to [Ca2+]i buffer-
ing (Matsuda et al. 1997). KB-R7943 may also reduce the
activity of VSSC and L-type VSCC (Iwamoto et al. 1996),
but this does not account for the observed effects on Li+
uptake as specific inhibition of the channels with TTX and
nifendipine, respectively, had minor effects on the transport
of the cation under our experimental conditions. However, it
was shown that stimulation of VSSC with veratridine causes
an increase on Li+ influx apparent rate constant in SH-SY5Y
cells and this effect was completely reverted by TTX
(Nikolakopoulos et al. 1998).
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Stimulation of SH-SY5Y cells with forskolin increased the
[Ca2+]i, in agreement with previous findings in GT1-7 cells
(Kaneishi et al. 2002), somatotropes (Holl et al. 1989) and in
myocytes (Xiong et al. 2001). The effect of intracellular
accumulation of cAMP on the [Ca2+]i was reduced in the
presence of KT-5720, indicating that it is mediated by PKA
activation. Pre-incubation of the cells with the N-type VSCC
blocker also inhibited the effect of forskolin on the [Ca2+]i,
indicating that PKA activation somehow leads to the
depolarization of the membrane and activation of Ca2+
channels. In contrast, inhibition of L-type VSCC was
without effect on forskolin-induced [Ca2+]i rise, indicating
that N-type VSCC was selectively recruited. Because TTX
was also without effect on the [Ca2+]i response to forskolin,
the effect was not mediated by activation of VSSC sensitive
to the toxin. Inhibition of the Na+/Ca2+ exchanger during the
period of stimulation with forskolin further increased the
[Ca2+]i, indicating that Ca
2+ taken up by the cells through
N-type VSCC is extruded by the antiporter.
In SH-SY5Y cells treated with 1 mM of Li+ the observed
decrease in forskolin-induced cAMP production demonstrates
the inhibitory effect of Li+ on AC at therapeutic concentra-
tions. These results confirm previous in vitro studies showing
that Li+ inhibits forskolin-stimulated AC activity (Newman
and Belmaker 1987; Mørk and Geisler 1989a). Forskolin is
thought to interact directly with the catalytic unit of AC
(Bender and Neer 1983; Seamon 1981). Moreover, it is well
known that Mg2+ is essential for the activity of this enzyme
(Sulakhe and Hoehn 1984). As Li+ and Mg2+ have similar
physicochemical properties (Frausto da Silva and Williams
1976), Li+may interfere with themodulatory effect ofMg2+ by
competing for Mg2+ binding sites in biomolecules (Mørk and
Geisler 1987a; Ramasamy et al. 1989; Mota de Freitas et al.
1994; Layden et al. 2000; Ryves and Harwood 2001). This
effect may explain the inhibitory effect of Li+ observed in the
present study. Although Li+ was shown to activate phospho-
diesterase (Smith 1990), this does not account for the observed
decrease in cAMP levels, as a selective inhibitor of phospho-
diesterase 4 was used (Reeves et al. 1987). This phospho-
diesterase isoform is expressed in SH-SY5Y cells and plays a
major role in cAMP hydrolysis (Jang and Juhnn 2001).
The increase in basal cAMP levels after 1 mM Li+
treatment at incubation times longer than 1 h is consistent
with results from in vitro and ex vivo experiments (Ebstein
et al. 1980; Newman and Belmaker 1987), as well as with
in vivo microdialysis studies (Masana et al. 1991; Masana
et al. 1992). The increase of cAMP basal levels by Li+ has
been attributed to inhibition of Gi, which is the G-protein
preferentially activated under basal conditions (Jope 1999b;
Brunello and Tascedda 2003). In resting conditions 1 h may
not be enough to inhibit Gi leading to the increase in cAMP.
However, a progressive increase in cAMP levels with time
was observed until a maximal value was reached at 24 h,
which was then maintained until 48 h. Under basal
conditions cAMP levels at 24 and 48 h of incubation with
Li+ were not significantly different from those obtained after
forskolin stimulation for the same Li+ incubation periods,
thus suggesting a total inhibitory effect of Li+ on the
stimulation of AC by forskolin.
Taken together, our results indicate that cAMP regulates
Li+ uptake and intracellular Li+ also controls AC activity.
This suggests that under basal conditions, cAMP levels are
low leading to a low Li+ influx. Once Li+ is inside the cells it
might raise cAMP levels thereby promoting its own influx.
When cAMP production is up-regulated, Li+ influx is
increased and may then reduce the stimulated production
of cAMP. Overall, the inhibitory effect of Li+ on Gi, which
results in elevated basal levels of cAMP, and the attenuation
of forskolin-induced increases in cAMP production, by direct
interaction with the catalytic unit of AC, may reduce the
magnitude of fluctuations in cAMP levels. The present
results are in agreement with the stabilizing effect of Li+ in
the homeostasis of intracellular cAMP in SH-SY5Y cells.
The present study also suggests that the mechanism of mood
stabilizing effects of Li+ is not due to a selective interference
with any particular neurotransmitter system, but rather affects
the functional balance between interacting systems (Masana
et al. 1992; Manji et al. 1995; Jope 1999a; Jope 1999b).
Preclinical and clinical studies suggest that the pathophys-
iological basis of bipolar disorder involves disturbances in the
cAMP signal transduction system and that the mood-stabil-
izing agent, Li+ interferes with this pathway (Chang et al.
2003). It is also known that Ca2+ (in micromolar concentra-
tions) stimulates some AC isoforms through calmodulin
(Lakey et al. 1985; Tang et al. 1991) indicating that there is a
cross-talk between Ca2+ regulatory and cAMP signaling
systems. As disturbances in both G-protein mediated cAMP
and Ca2+-signaling have been reported in bipolar disease
(Emamghoreishi et al. 2000), cross-talk regulatory mecha-
nisms are potentially important candidates to explain abnor-
malities in these two signal transduction pathways. Thus,
increased [Ca2+]i reported in bipolar disorder might result
from altered G-protein function, also identified in these
patients, or vice versa. Additionally, it was found that Li+
bipolar responders have a higher [Ca2+]i than patients with
normal calcium levels, which indicates a correlation between
intracellular Ca2+ levels and lithium response (Ikeda and Kato
2003).
Our studies demonstrate a direct correlation between
stimulated increase of intracellular cAMP levels, increased
[Ca2+]i and increase of Li
+ uptake by neuronal cells, which
may contribute to a better understanding of the mechanism of
Li+ action in the treatment of bipolar disorder.
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